October 2024
The global syringes and injectable drugs packaging market is set for a massive revenue upswing, with projections of growth reaching hundreds of millions of dollars.
The syringes and injectable drugs packaging market is set to expand substantially over the forecast timeline. In the last decade, the healthcare sector has undergone an enormous shift, particularly in the manufacturing of medical devices and packaging for injectable drugs and syringes has been particularly affected segment. The growing inclination current consumers towards prefilled syringes are driving the modifications in syringe packaging. The majority of the patients prefer self-administered injections instead of the facility-based treatment and consumers now have wider access to biological medicines that need subcutaneous injections. In the end, maintaining the quality and purity of the delicate liquid medication in the prefilled syringe is the primary function of syringe packing.
The growing occurrence of chronic diseases along with the expansion of biologics and biosimilars is expected to augment the growth of the syringes and injectable drugs packaging market during the forecast period. Furthermore, the stringent regulatory mandates requiring stringent standards for sterility and patient safety as well as the shift towards injectable drugs are also anticipated to augment the growth of the market. Additionally, the increased adoption of self-administration devices and healthcare infrastructure expansion in the emerging economies coupled with the rise of aging population is also projected to contribute to the growth of the market in the years to come. The global packaging industry size is estimated to grow from USD 1.20 trillion in 2022 to reach an estimated USD 1.58 trillion by 2032, growing at a 3.16% CAGR between 2023 and 2032.
The rising prevalence of chronic diseases such as diabetes, cancer and autoimmune disorders is projected to support the growth of the syringes and injectable drugs packaging market during the forecast period. This is owing to the global increase in aging populations. According to the report by the United Nations Department of Economic and Social Affairs Population Division, over the years to come, population aging will be a global phenomenon experienced by all the regions. It is projected that developed nations would enter the next phase of population aging, with a 20% increase in the percentage of older people in 2023 to a 28% increase in 2050. This percentage also increases to 17 percent for other developing countries (ODCs) from 9 percent. Though currently at a lower level, the least developed nations (LDCs) are predicted to rise more quickly throughout this time, by over 180%, from roughly 4% to over 6%. As people live longer the likelihood of developing the age-related chronic conditions such as diabetes and cancer also increases.
Additionally, the unhealthy diets, physical inactivity along with the rising obesity rates are all contributing to the surge in the metabolic disorders like diabetes. With chronic conditions requiring ongoing treatment, injectable drugs have become a primary method of drug administration. For example, insulin injections are important for diabetes management, while injectable biologics are increasingly used in the cancer as well as the autoimmune disease therapies. More than 80% of the chronic biologics delivered subcutaneously with the utilization of the prefilled syringes. Pre-filled retractable safety syringes are frequently utilized for medication delivery, and they are increasingly being built with needle protecting safety features to meet with severe safety laws. This demand for the injectable medications directly impacts the need for safe and reliable packaging options that guarantee sterility, proper dosing and ease of use. Prefilled syringes, auto-injectors and single-use vials are being developed to meet the needs of the patients and healthcare professionals, offering convenience and reducing the risk of contamination.
Pharmaceutical firms face barriers as syringes become increasingly popular, especially in terms of keeping a sterile and clean environment when packing them. Due to the injectable drug's nature, there is a significant risk to health as any contamination could enter the bloodstream directly. Compared to other dosage media, prefilled syringe secondary packaging is very different. The process can be significantly more complicated compared with other formats due to the dosage form's variable packaging design. Irrespective of which syringe is being used, the only parts that are constant are the plunger rod and the label. In addition to it, a safety device, a loose or staked needle and occasionally an extra finger flange on the safety device may be included, depending on the requirements of the medication or the patients utilizing it.
Furthermore, extra inserts like the alcohol pads or several booklets are frequently found and these further complicate the packaging procedure. Companies must be able to add, delete, or modify any or all of these components with the necessary flexibility. Each of these components must be carefully studied. In order to preserve the product safety, sterility and reduce the danger of contamination as well as to make sure that all required components are present and the drug product is maintained in the proper circumstances, a number of process points must be regulated and monitored. Ignoring these concerns may result in the delivery of unsafe formulations that are not appropriate for the patient use. Also, as packaging volumes increase to meet rising demand, preserving sterility across mass manufacturing scales adds another degree of complexity, making it a significant barrier for pharmaceutical companies to overcome.
The trend towards home-based care and self-administration is anticipated to augment the growth of the syringes and injectable drugs packaging market in the near future. Although there has previously been an increase in care at home services due to the rising cost of healthcare and the increasing disease burden, the COVID-19 pandemic served as a catalyst to truly reinvent the future. More people are able to receive care at home due to the new technologies such as the remote patient monitoring systems that help healthcare professionals keep an eye on a patient's progress from a distance and notify them of any problems. Remote patient monitoring has become more popular since the outbreak of the pandemic. The Mayo Clinic, for instance, utilized the remote patient monitoring for the ambulatory management of COVID-19 patients and discovered that it was successful, as evidenced by a 78.9 percent engagement rate, 11.4 percent and 9.4 percent 30-day hospitalization and emergency department visit rates, respectively.
Furthermore, the baby boomer generation's retirement is driving up the need for home and community-based services (HCBS). Industry observers predict that by 2050, there will be more than 80 million senior citizens. The number of caretakers per senior person could drastically decline due to the steep growth in the elderly population, provided that existing job and retirement patterns remain unchanged. The demand will also increase as a result of a possible increase in the Medicaid funds, which is a component of the $150 billion that the Biden administration has committed to the HCBS. Auto-injectors and prefilled syringes are designed for self-administration, allowing the non-professional users to safely and properly take their medication without the need for medical help. These devices increase the patient independence and promote compliance to treatment regimens, making them particularly appealing to the expanding number of patients who want or require home care management.
The plastic segment is likely to grow at a considerable CAGR during the forecast period. Syringes are utilized in the fields of veterinary and medical science and are made up of plastic. Most disposable syringes are made of polypropylene through injection molding. Disposable syringes are quickly replacing the traditional glass syringes as they are readily available in sterilized condition, simple to use and are reasonably priced. Sterilization and sterility maintenance of plastic syringes during production and packing is also simple. Pre-sterilization of disposable plastic syringes lowers the possibility of infection during the surgical operations. Additionally, the plastics used in syringes are non-reactive and do not leach chemicals into the drug, protecting the patient. The most prominent advantage is the prevention of the transmission of illnesses. When disposable syringes are used properly, blood-borne infections are virtually eliminated. These factors are likely to support to the segment growth within the estimated timeframe.
The hospitals segment held largest market share in 2023. Hospitals are major consumers of syringes, vials, ampoules, and other injectable drug packaging due to the high volume of medical procedures, including surgeries, vaccinations, and treatments for acute and chronic conditions. Customers select hospitals due to the range of specialists and staff members available, as well as how easy it is to retrieve their data on electronic health records. Furthermore, hospitals give their clients access to a wide range of services, resources and products. Additionally, the focus on the patient safety and infection control in the hospitals increases the demand for safety syringes, which help lower the possibility of cross-contamination as well as needle-stick injuries. Hospitals continue to be the major consumers of these packaging options, owing to their ability to handle complex treatments and a wide range of patient needs.
North America held considerable market share in 2023. This is due to the high incidence of chronic conditions such as cancer, diabetes and cardiovascular diseases and the surge in the production of injectable drugs and biologics across the region. According to the estimates by the National Diabetes Statistics Report, 38.4 million people of all ages, equal to 11.6% of the population of the U.S. had diabetes in 2021 and diabetes prevalence climbed up with the increasing age, reached 29.2% among people 65 years old and older. Furthermore, the well-established healthcare facilities, including hospitals, clinics and ambulatory care services is also expected to contribute to the regional growth of the market. Also, the stringent regulations for drug safety and packaging are further expected to support regional growth of the market in the years to come.
Asia Pacific is likely to grow at fastest CAGR during the forecast period. This is owing to the expanding healthcare infrastructure in emerging economies like China and India with significant investments. As per the data by the India Brand Equity Foundation, to improve the nation's healthcare infrastructure, the Indian government intends to launch a credit incentive scheme valued at Rs. 50,000 Crore (US$ 6.8 billion). Additionally, the rapidly aging population along with the growing home-based care and self-administration is also anticipated to promote the growth of the market in the region in the years to come.
Some of the key players in syringes and injectable drugs packaging market DuPont (Tyvek), Sharp Services, LLC, Harro Höfliger Packaging Machines GmbH, West Pharmaceutical Services, Inc., Stoelzle Pharma, AptarGroup, Inc., CCL Healthcare, Prent Corporation, Tjoapack LLC, HySum Europe GmbH, Gerresheimer AG and Terumo Europe NV, among others.
By Material Type
By Product Type
By End-User
By Region
October 2024
October 2024
October 2024
October 2024
Asmita Singh is a distinguished author and consultant in the packaging industry, recognized for her unwavering passion for knowledge discovery and her commitment to providing actionable insights. She holds an MBA from the University of Mumbai and a degree in Packaging Engineering from the Indian Institute of Packaging (IIP), equipping her with a solid foundation in both business and technical aspects of packaging. With extensive experience in packaging consulting, Asmita has successfully implemented advanced research methodologies across various packaging categories, including flexible packaging, rigid packaging, sustainable packaging, and smart packaging. She generates high-quality data and delivers meaningful results that drive innovation and efficiency. Her expertise spans the globe, offering valuable consulting services to businesses seeking to enhance their packaging strategies. Asmitas work is characterized by a dedication to excellence and a keen understanding of the latest trends and technologies shaping the future of packaging.